Application of dexmedetomidine in children with agitation during ventilator weaning.
- Author:
Jie HE
1
;
Xin-Ping ZHANG
;
Mei-Yu YANG
;
Yuan-Hong YUAN
;
Xiong ZHOU
;
Wen-Jiao ZHAO
;
Zheng-Hui XIAO
Author Information
1. Emergency Center, Hunan Children's Hospital, Changsha 410007, China. xiaozhh8888@163.com.
- Publication Type:Journal Article
- MeSH:
Child;
Dexmedetomidine;
Humans;
Hypnotics and Sedatives;
Prospective Studies;
Respiration, Artificial;
Ventilator Weaning
- From:
Chinese Journal of Contemporary Pediatrics
2019;21(6):522-527
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the clinical effect and safety of dexmedetomidine in children with agitation during ventilator weaning.
METHODS:A prospective open observational study was performed for children who were admitted to the intensive care unit and experienced mechanical ventilation between March 2017 and August 2018. They were given dexmedetomidine due to the failure in the spontaneous breathing test (SBT) caused by agitation. A sedation-agitation scale score of ≥5 was defined as agitation. The children were observed in terms of the sedation state at 0.5, 1, 2, 6, and 12 hours after the administration of dexmedetomidine, blood gas parameters before extubation and at 1, 24, and 48 hours after extubation, vital signs (heart rate, respiratory rate and mean arterial pressure) before SBT, before extubation, and at 10, 60, and 120 minutes and 24 hours after extubation, and incidence rates of adverse events related to the use of dexmedetomidine.
RESULTS:A total of 19 children were enrolled in this study. All the children were in a state of agitation at the time of enrollment. At 0.5, 1, 2, 6, and 12 hours after the administration of dexmedetomidine, 12, 17, 17, 18, and 18 children respectively reached the sedation state. There were no significant differences in the oxygenation index, arterial partial pressure of carbon dioxide, heart rate, respiratory rate, and mean arterial pressure at each time point before and after extubation (P>0.05). No adverse events were observed, such as severe hypotension and respiratory depression, and only one child experienced reversible bradycardia.
CONCLUSIONS:Dexmedetomidine is safe and effective in children with agitation during ventilator weaning, but prospective randomized controlled trials are needed for verification.
